Stephen C McCluski's Net Worth
$4.85 Million
Estimate Recalculated Feb 16, 2024 02:03PM EST
Who is Stephen C McCluski?
Stephen C McCluski has an estimated net worth of $4.85 Million. This is based on reported shares across multiple companies, which include ImmunoGen, Inc., MONRO, INC., STANDARD MICROSYSTEMS CORP, BAUSCH & LOMB INC, and INDEVUS PHARMACEUTICALS INC.
SEC CIK
Stephen C McCluski's CIK is 0001188728
Past Insider Trading and Trends
2004 was Stephen C McCluski's most active year for acquiring shares with 27 total transactions. Stephen C McCluski's most active month to acquire stocks was the month of July. 2005 was Stephen C McCluski's most active year for disposing of shares, totalling 21 transactions. Stephen C McCluski's most active month to dispose stocks was the month of July. 2005 saw Stephen C McCluski paying a total of $3,520,835.20 for 103,371 shares, this is the most they've acquired in one year. In 2004 Stephen C McCluski cashed out on 108,412 shares for a total of $3,673,519.74, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ImmunoGen, Inc. (IMGN) Snapshot price: $29.595
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
$15.38 | -$13,500.00 |
0
|
Sep 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 16 - Nov 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MONRO, INC. (MNRO) Snapshot price: $32.01
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +25.10% | 3.75K |
—
|
—
| 18.68K |
Aug 15
| |||
Form 4
| +19.39% | 2.43K |
—
|
—
| 14.94K |
Aug 16
| |||
Form 4
| +23.14% | 2.35K |
—
|
—
| 12.51K |
Aug 17
| |||
Form 4
|
—
|
0
|
$58.22 | -$8,728.00 | 10.16K |
Aug 6
| |||
Form 4
| +33.95% | 2.58K |
—
|
—
| 10.16K |
Aug 18
| |||
Form 4
| +28.04% | 1.66K |
—
|
—
| 7.58K |
Aug 13
| |||
Form 4
|
—
|
0
|
$64.56 | -$261,037.40 | 5.92K |
Feb 14
| |||
Form 4
| +44.64% | 1.83K |
—
|
—
| 5.92K |
Aug 14
| |||
Form 4
|
—
|
0
|
$49.99 | -$110,500.00 | 4.09K |
Feb 5
| |||
Form 4
| +241.25% | 2.9K |
—
|
—
| 4.09K |
Aug 15
| |||
Form 4
|
∞
| 1.2K |
$46.45 | $55,736.16 | 1.2K |
Jul 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
STANDARD MICROSYSTEMS CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -4.87K |
$37.00 | -$180,079.00 |
0
|
Aug 2
| |||
Form 4
| +3.69% | 173 |
—
|
—
| 4.87K |
Jul 16
| |||
Form 4
| +5.51% | 245 |
—
|
—
| 4.69K |
Apr 16
| |||
Form 4
| +6.36% | 266 |
—
|
—
| 4.45K |
Jan 17
| |||
Form 4
| +7.48% | 291 |
—
|
—
| 4.18K |
Oct 17
| |||
Form 4
| +6.98% | 254 |
—
|
—
| 3.89K |
Jul 15
| |||
Form 4
| +7.54% | 255 |
—
|
—
| 3.64K |
Apr 15
| |||
Form 4
| +8.15% | 255 |
—
|
—
| 3.38K |
Jan 18
| |||
Form 4
| +9.26% | 265 |
—
|
—
| 3.13K |
Oct 15
| |||
Form 4
| +10.46% | 271 |
—
|
—
| 2.86K |
Jul 15
| |||
Form 4
| +9.74% | 230 |
—
|
—
| 2.59K |
Apr 15
| |||
Form 4
| +13.78% | 286 |
—
|
—
| 2.36K |
Jan 15
| |||
Form 4
| +16.69% | 297 |
—
|
—
| 2.08K |
Oct 15
| |||
Form 4
| +19.88% | 295 |
—
|
—
| 1.78K |
Jul 15
| |||
Form 4
| +33.81% | 375 |
—
|
—
| 1.48K |
Apr 15
| |||
Form 4
| +64.30% | 434 |
—
|
—
| 1.11K |
Jan 15
| |||
Form 4
|
∞
| 675 |
—
|
—
| 675 |
Oct 15
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BAUSCH & LOMB INC No price found
Senior Vice President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 4
| +6.47% | 1.44K |
$51.53 | -$35,452.64 | 23.61K |
Apr 3
| |||
Form 4
|
∞
| 611 |
—
|
—
| 611 |
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
| +22.68% | 3.95K |
—
|
—
| 21.37K |
Feb 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 17
| |||
Form 4
|
—
|
0
|
$58.01 | -$1,140,374.00 | 17.36K |
Scheduled
|
Aug 10
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
| -2.80% | -500.00 |
—
|
—
| 17.34K |
May 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
| -21.48% | -4.87K |
$72.90 | -$381,923.10 | 17.81K |
Scheduled
|
Feb 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 31
| |||
Form 4
| -3.25% | -761.00 |
$66.21 | -$50,382.00 | 22.68K |
Jan 25
| |||
Form 4
| +0.19% | 33 |
$63.40 | $2,092.20 | 17.44K |
Jan 4
| |||
Form 4
|
—
|
0
|
$51.50 | -$444,000.00 | 23.41K |
Scheduled
|
Nov 10
| ||
Form 4
| -17.60% | -5.00K |
$60.90 | -$304,500.00 | 23.41K |
Scheduled
|
Nov 3
| ||
Form 4
| +0.18% | 31 |
$67.00 | $2,077.00 | 17.41K |
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 18
| |||
Form 4
| -13.69% | -4.50K |
$61.50 | -$276,750.00 | 28.37K |
Scheduled
|
Aug 3
| ||
Form 4
| +0.14% | 24 |
$64.28 | $1,542.72 | 17.37K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
| +0.17% | 30 |
$61.67 | $1,850.10 | 17.35K |
Apr 1
| |||
Form 4
| -1.20% | -400.00 |
$48.10 | -$132,409.20 | 32.82K |
Scheduled
|
Mar 8
| ||
Form 4
| -2.07% | -702.00 |
$59.10 | -$41,490.54 | 33.22K |
Feb 26 - Feb 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
| +2.28% | 365 |
—
|
—
| 16.4K |
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
| -18.58% | -4.00K |
—
|
—
| 17.52K |
Jan 27
| |||
Form 4
| +0.21% | 33 |
$51.62 | $1,703.46 | 16.03K |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
| 37.52K |
Dec 8
| |||
Form 4
| -25.43% | -4.07K |
$51.78 | -$210,640.52 | 11.93K |
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 4
| +0.20% | 32 |
$45.50 | $1,456.00 | 16K |
Oct 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
INDEVUS PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 23 - Feb 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
| No matching records found | |||||||||